Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC (2021)

First Author: Haragan A.

Attributed to: Immune-checkpoint therapy in non-small cell lung carcinoma:molecular characterisation of tumour microenvironment to improve anti-PD1/PD-L1 drug class. funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 16

Parent Publication: JOURNAL OF THORACIC ONCOLOGY

Issue: 3

ISSN: 1556-0864